Cargando…
Kidney cancer: The next decade
Chris Boshoff, Senior Vice President of Immuno-Oncology, Translational and Early Development at Pfizer, and colleagues Samra Turajlic and Charles Swanton from the Francis Crick Institute and University College London give us their personal point of view on new insights and future therapeutic approac...
Autores principales: | Turajlic, Samra, Swanton, Charles, Boshoff, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170181/ https://www.ncbi.nlm.nih.gov/pubmed/30217855 http://dx.doi.org/10.1084/jem.20181617 |
Ejemplares similares
-
Senior care costs and demand will nearly double in the next decade
por: Duong, Diana
Publicado: (2021) -
Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection
por: Flynn, Michael, et al.
Publicado: (2018) -
Lost decade 'undermining dentistry's pandemic recovery'
Publicado: (2021) -
Lost decade on pay undermining NHS dentistry's COVID recovery
Publicado: (2021) -
Preventing the next pandemic
Publicado: (2021)